Medical Briefs
  • Home
  • Topic
    • All
    • Cardiology
    • Emergency care
    • Endocrinology
    • Gynecology
    • Infectious
    • Oncology
    • Pharmacology
    • Primary Care
    • Research
    • Surgery
    neurosurgery-procedure-for-glioma-remova

    Intraoperative Imaging in Glioma Surgery: A Cochrane Review

    vitamin e and liver

    Vitamine E and fatty liver disease : A Cochrane review

    melatonin’s anticancer effects

    Melatonin in Cancer Prevention and Treatment

    obesity and BMI

    High BMI in Children: USPSTF

    AI for macular Degeneration

    AI as for Age-Related Macular Degeneration: A Cochrane Review

    TXA and PPH

    Tranexamic Acid For PPH after C-Sections: A Cochrane Review

    COVID-19 vaccine

    Safety Of COVID-19 Vaccination in pregnancy

    Stem cells and Myocardial infarction

    Stem Cell and Acute Mycordial Infarction: A Cochrane

    cranberry uti

    Cranberry and UTI: A Cochrane

  • Contact Us
  • About Us
No Result
View All Result
  • Home
  • Topic
    • All
    • Cardiology
    • Emergency care
    • Endocrinology
    • Gynecology
    • Infectious
    • Oncology
    • Pharmacology
    • Primary Care
    • Research
    • Surgery
    neurosurgery-procedure-for-glioma-remova

    Intraoperative Imaging in Glioma Surgery: A Cochrane Review

    vitamin e and liver

    Vitamine E and fatty liver disease : A Cochrane review

    melatonin’s anticancer effects

    Melatonin in Cancer Prevention and Treatment

    obesity and BMI

    High BMI in Children: USPSTF

    AI for macular Degeneration

    AI as for Age-Related Macular Degeneration: A Cochrane Review

    TXA and PPH

    Tranexamic Acid For PPH after C-Sections: A Cochrane Review

    COVID-19 vaccine

    Safety Of COVID-19 Vaccination in pregnancy

    Stem cells and Myocardial infarction

    Stem Cell and Acute Mycordial Infarction: A Cochrane

    cranberry uti

    Cranberry and UTI: A Cochrane

  • Contact Us
  • About Us
No Result
View All Result
Medical Briefs
No Result
View All Result
Home Topic Cardiology

A Fresh Perspective on Identifying Left Bundle Branch Block

Kiarash Ansari by Kiarash Ansari
April 7, 2024
in Cardiology, Topic
0
A Fresh Perspective on Identifying Left Bundle Branch Block
0
SHARES
19
VIEWS
Share on FacebookShare on Twitter

A groundbreaking study recently published in JAMA Cardiology has introduced a new criterion for diagnosing Left Bundle Branch Block (LBBB), a heart condition that can lead to irregular heart rhythms and heart failure. This research was spearheaded by a team of medical professionals from the University of Chicago Pritzker School of Medicine.

The Shortcomings of Existing Criteria

The current diagnostic criteria for LBBB are largely based on animal experiments or mathematical models of cardiac tissue conduction. These methods, however, have been found to potentially misclassify patients, leading to inappropriate treatment decisions. For example, patients may be referred for cardiac resynchronization therapy (CRT) or conduction system pacing (CSP) based on an inaccurate diagnosis. This highlights the urgent need for improved criteria that can more accurately guide referral decisions and the choice of device for cardiac resynchronization therapy.

Introducing the New Criterion

The researchers set out to develop a straightforward new criterion for LBBB, drawing on electrophysiological studies of human patients. This criterion was then validated in an independent population. The study involved patients who underwent an electrophysiological study from March 2016 through November 2019. The validation cohort was assembled by retrospectively reviewing medical records of patients who underwent transcatheter aortic valve replacement (TAVR) from October 2015 through May 2022.

The team discovered that late notches in the QRS complexes of lateral leads were associated with complete conduction block (CCB). They suggested that a time to notch longer than 75 milliseconds in lead I is a simple ECG criterion that, when used alongside standard LBBB criteria, may enhance specificity for identifying patients with LBBB from conduction block. This could potentially improve patient selection for cardiac resynchronization or conduction system pacing.

Measurement of Notch Times: Time to notch is measured as the time from QRS onset to the nadir of the notch
or midpoint of a slur. If multiple notches or slurs are present in the QRS
complex, the latest one is used. The measurement shown demonstrates a time
to notch of approximately 90 milliseconds in lead I.

Validating the New Criterion

The new criterion was validated on an independent dataset comprising patients who acutely developed periprocedural LBBB during TAVR implant. The sensitivity of the new criterion remained high in this cohort. Interestingly, in a small subset of patients with prior intraventricular conduction delay (IVCD), the criterion demonstrated perfect accuracy in distinguishing IVCD from LBBB.

Clinical Implications of the Study

The results of this study carry significant clinical implications for patient selection for cardiac resynchronization. Previous research has shown that wide QRS in patients with intact Purkinje activation (IPA) cannot be corrected with CSP and patients may not respond clinically; thus, they should be given a traditional biventricular CRT system if cardiac resynchronization is attempted. The new criterion proposed in this study offers a simple yet specific assessment to assist in procedural planning.

In conclusion, this study proposes a simple new surface ECG criterion for LBBB based on direct electrophysiological observations in human patients. The new criterion significantly improved specificity in the derivation cohort, with better testing performance than the Strauss criteria. This work may have implications in choosing patients for CRT and CSP.

Tags: CardiologyLBBB
Previous Post

PAXLOVID

Next Post

Bispecific antibodies, a promising class of therapeutics in cancer therapy

Kiarash Ansari

Kiarash Ansari

Next Post
Bispecific antibodies, a promising class of therapeutics in cancer therapy

Bispecific antibodies, a promising class of therapeutics in cancer therapy

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Intraoperative Imaging in Glioma Surgery: A Cochrane Review
  • Vitamine E and fatty liver disease : A Cochrane review
  • Melatonin in Cancer Prevention and Treatment
  • High BMI in Children: USPSTF
  • AI as for Age-Related Macular Degeneration: A Cochrane Review

Recent Comments

No comments to show.

Follow for More

Medical Briefs

Medical Briefs

The Medixbrief is a premier source of up-to-date, evidence-based medicine content that is geared toward providing physicians with relevant and therapeutic information to aid in their practice

Categories

  • Cardiology
  • Emergency care
  • Endocrinology
  • Gynecology
  • Infectious
  • Oncology
  • Pharmacology
  • Primary Care
  • Research
  • Surgery
  • Topic

Follow us

  • facebook
  • x
  • instagram
  • linkedin
  • mail

Archives

  • November 2024
  • September 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • About Us
  • Contact Us
  • Home
  • Patient Education
  • Posts
  • Surgery

© 2023 Medixbrief All rights reserved.

No Result
View All Result
  • Home
  • Topic
  • Contact Us
  • About Us

© 2023 Medixbrief All rights reserved.